Respiratory Illnesses : Vaccination Trends—Adults
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Respiratory Illnesses : Vaccination Trends—Adults

Filetype[PDF-349.89 KB]


English

Details:

  • Corporate Authors:
  • Description:
    This page provides an update on receipt of vaccination and intent for vaccination among adults for COVID-19, RSV, and influenza based on weekly updated Immunization Survey (NIS) findings. NIS estimates reported below are based on survey responses rather than vaccine records, or administrations. During the COVID-19 Public Health Emergency (PHE), CDC tracked nearly all COVID-19 vaccines administered. However, the end of the PHE limits the completeness of COVID-19 vaccine administration data CDC receives. As a result, survey data are now the primary source for tracking receipt of vaccination for COVID-19, as well as for influenza and RSV, among adults.

    Vaccination Trends:

    • The percent of the population reporting receipt of COVID-19, influenza, and RSV vaccines remains low for children and adults.

    • The percent of the population reporting receipt of the updated 2023-24 COVID-19 vaccine is 14.1% (95% confidence interval: 13.6-14.6) for children and 22.5% (22.1-22.8) for adults 18+, including 40.8% (39.7-41.8) among adults age 65+.

    • The percent of the population reporting receipt of a flu vaccine is 53.4% (95% confidence interval: 52.5-54.3) for children and 48.6% (48.0-49.1) for adults 18+, including 73.5% (72.2-74.9) among adults age 65+.

    • The percent of adults age 60+ that report receiving an RSV vaccine is 24.4% (23.6-25.2).

    Reported on Friday, May 10th, 2024.

  • Subjects:
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov